Indivior launches generic version of opioid drug after losing court battle

Indivior Plc has launched a copycat of its blockbuster opioid addiction drug in the United States, the British drugmaker said on Wednesday, after losing a long-drawn court battle to prevent entry of generic rivals in its biggest market. (Source: Reuters: Health)MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.